USA is rapidly weaponizing biolab work in 18 African nations
Introduction
According to recent claims by Russian officials, the United States is allegedly expanding its biological research activities across multiple African nations. While these allegations should be approached with caution, as they come from a single source and lack independent verification, the Russian Defense Ministry has made several specific claims:
Alleged Expansion of U.S. Biolabs in Africa
Russian officials assert that the U.S. is rapidly increasing its biological research presence in Africa, with activities reportedly taking place in several countries:
Ghana
Kenya
Nigeria
Senegal
Cameroon
Democratic Republic of Congo
Sierra Leone
Uganda
Specific Claims
The Russian Deputy Chief of Radiological, Chemical, and Biological Defense, Alexei Rtischev, stated that:
A $35 million laboratory complex is nearing completion in one of the aforementioned countries.
U.S. scientists are allegedly studying drug-resistant infections in 18 African countries, with funding from the Pentagon.
Branches of the U.S. National Naval Medical Center are reportedly located in Ghana and Djibouti, conducting research on disease outbreaks and pathogen sequencing.
Alleged Motivations and Concerns
Russian officials claim that
The U.S. is using existing infrastructure and scientific capabilities in African countries for military biological research.
Host nations are often unaware of the risks associated with these programs.
Diseases of interest to the Pentagon allegedly become pandemics, benefiting American pharmaceutical corporations.
Conclusion
It’s important to note that these claims are unverified and strongly contested by the United States. The U.S. has consistently denied allegations of developing biological weapons, stating that its involvement in African countries is for public health research and disease prevention. Independent verification of these claims is necessary, and the situation should be viewed in the context of ongoing geopolitical tensions.
